Search research articles
Contact Us
Filters
Showing results (381-390 of 477) with videos related to
Page
of 48
Sort By:
Journal of Gastroenterology and Hepatology
|
October 18, 2025
Clinical Profile and Predictors of Repeated Relapse in Type 1 Autoimmune Pancreatitis: A Multicenter Observational Study
Sho Saeki, Yasutaka Ishii, Keiji Hanada, et al.
Gerontology
|
April 30, 2026
Safety and efficacy of oral tacrolimus induction therapy in elderly patients with ulcerative colitis: A subanalysis of a large multicenter retrospective cohort study
Toshihiro Inokuchi, Sakiko Hiraoka, Naoki Oshima, et al.
Journal of Gastroenterology
|
February 15, 2017
Long-term outcomes after treatment for T1 colorectal carcinoma: a multicenter retrospective cohort study of Hiroshima GI Endoscopy Research Group
Yuzuru Tamaru, Shiro Oka, Shinji Tanaka, et al.
JMIR Research Protocols
|
March 31, 2026
Multidisciplinary Treatment With Hepatic Arterial Infusion Chemotherapy, Radiotherapy, and Immunotherapy for Advanced Hepatocellular Carcinoma With Major Vascular Invasion: Prospective Registry Protocol
Yoshiko Doi, Hiroshi Aikata, Yumi Kosaka, et al.
Esophagus : Official Journal of the Japan Esophageal Society
|
April 7, 2023
Endoscopic findings suggestive of a high risk of non-radical cure after definitive chemoradiotherapy for cT1bN0M0 esophageal squamous cell carcinoma
Motomitsu Fukuhara, Yuji Urabe, Shiro Oka, et al.
Journal of Gastroenterology
|
December 9, 2024
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
Ryoichi Miura, Atsushi Ono, Hikaru Nakahara, et al.
Cancers
|
April 13, 2024
Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma
Yuki Shirane, Yasutoshi Fujii, Atsushi Ono, et al.
Journal of Gastroenterology
|
February 24, 2022
Clinicopathological characteristics of colorectal serrated polyposis syndrome (SPS): results of a multicenter study by the SPS Study Group in Japan
Yasutsugu Shimohara, Yuji Urabe, Shiro Oka, et al.
Microorganisms
|
May 4, 2026
A Study on the Association Between Treatment Response to Atezolizumab Plus Bevacizumab Combination Therapy for Advanced Hepatocellular Carcinoma and Gut Microbiota
Yusuke Tanaka, Daiki Miki, C Nelson Hayes, et al.
Digestion
|
December 17, 2018
Recurrence Patterns and Outcomes of Salvage Surgery in Cases of Non-Curative Endoscopic Submucosal Dissection without Additional Radical Surgery for Early Gastric Cancer
Kohei Takizawa, Waku Hatta, Takuji Gotoda, et al.
Page
of 48
Search research articles
Search
Showing results (381-390 of 477) with videos related to
Sort By:
Page
of 48
Journal of Gastroenterology and Hepatology
|
October 18, 2025
Clinical Profile and Predictors of Repeated Relapse in Type 1 Autoimmune Pancreatitis: A Multicenter Observational Study
Sho Saeki, Yasutaka Ishii, Keiji Hanada, et al.
Gerontology
|
April 30, 2026
Safety and efficacy of oral tacrolimus induction therapy in elderly patients with ulcerative colitis: A subanalysis of a large multicenter retrospective cohort study
Toshihiro Inokuchi, Sakiko Hiraoka, Naoki Oshima, et al.
Journal of Gastroenterology
|
February 15, 2017
Long-term outcomes after treatment for T1 colorectal carcinoma: a multicenter retrospective cohort study of Hiroshima GI Endoscopy Research Group
Yuzuru Tamaru, Shiro Oka, Shinji Tanaka, et al.
JMIR Research Protocols
|
March 31, 2026
Multidisciplinary Treatment With Hepatic Arterial Infusion Chemotherapy, Radiotherapy, and Immunotherapy for Advanced Hepatocellular Carcinoma With Major Vascular Invasion: Prospective Registry Protocol
Yoshiko Doi, Hiroshi Aikata, Yumi Kosaka, et al.
Esophagus : Official Journal of the Japan Esophageal Society
|
April 7, 2023
Endoscopic findings suggestive of a high risk of non-radical cure after definitive chemoradiotherapy for cT1bN0M0 esophageal squamous cell carcinoma
Motomitsu Fukuhara, Yuji Urabe, Shiro Oka, et al.
Journal of Gastroenterology
|
December 9, 2024
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
Ryoichi Miura, Atsushi Ono, Hikaru Nakahara, et al.
Cancers
|
April 13, 2024
Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma
Yuki Shirane, Yasutoshi Fujii, Atsushi Ono, et al.
Journal of Gastroenterology
|
February 24, 2022
Clinicopathological characteristics of colorectal serrated polyposis syndrome (SPS): results of a multicenter study by the SPS Study Group in Japan
Yasutsugu Shimohara, Yuji Urabe, Shiro Oka, et al.
Microorganisms
|
May 4, 2026
A Study on the Association Between Treatment Response to Atezolizumab Plus Bevacizumab Combination Therapy for Advanced Hepatocellular Carcinoma and Gut Microbiota
Yusuke Tanaka, Daiki Miki, C Nelson Hayes, et al.
Digestion
|
December 17, 2018
Recurrence Patterns and Outcomes of Salvage Surgery in Cases of Non-Curative Endoscopic Submucosal Dissection without Additional Radical Surgery for Early Gastric Cancer
Kohei Takizawa, Waku Hatta, Takuji Gotoda, et al.
Page
of 48